Differential diagnosis of focal liver lesions using contrast-enhanced MRI with SHU 555 A in comparison with unenhanced MRI and multidetector spiral-CT;Dignitätsbeurteilung fokaler Leberläsionen mit der kontrastverstärkten MRT mit SHU 555 A im vergleich zur nativen MRT und zur mehrzeilen-detektor-spiral-CT

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 177, Issue 11, 2005, Pages 1571-1577

  Jung, Gregor ^a,c   Poll, L ^a   Cohnen, M ^a   Saleh, A ^a   Vogler, H ^b   Wettstein, M ^a   Willers, R ^a   Modder U ^a   Koch, J A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Business Unit Diagnostics   (Germany)

^c NONE   (Germany)

Author keywords

Abdomen; CT spiral; MR imaging; SPIO; Staging; Tissue characterization

Indexed keywords

IOPROMIDE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER CIRRHOSIS; LIVER TUMOR; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 28044473182     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858627     Document Type: Article

References (27)

1. Kang BK, Lim JH, Kim SH et al. Preoperative depiction of hepatocellular carcinoma: ferumoxides- enhanced MR imaging versus triple-phase helical CT. Radiology 2003; 226: 79-85
2. Bluemke DA, Paulson EK, Choti MA et al. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxide-enhanced MR-imaging and dual-phase helical CT. Am J Roentgenol 2000; 175: 1653-1658
3. Helmberger T, Gregor M, Holzknecht N et al. Detektion und Charakterisierung fokaler Leberläsionen: Vergleich von biphasischer, kontrastmittelverstärkter Spiral-CT, nativer und SPIO-verstärkter MRT. Radiologe 1999; 39: 678-684
4. Ward J, Naik KS, Guthrie JA et al. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999; 210: 459-466
5. Reimer P, Jahnke N, Fiebich M et al. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 2000; 217: 152-158
6. Foley WD, Mallisee TA, Hohenwalter MD et al. Multiphase hepatic CT with a multirow detector CT scanner. Am J Roentgenol 2000; 175: 679-685
7. Kulinna C, Helmberger T, Kessler M et al. Verbesserung der Diagnostik von Lebermetastasen mit der Multi-Detektor-CT. Radiologe 2001; 41: 16-23
8. Vogl TJ, Luboldt W, Herzog C et al. Kontrastverstärkte Mehrschicht-Computertomographie in der Detektion und Evaluation abdomineller Neoplasien. Radiologe 2002; 42: 646-654
9. Reimer P, Balzer T. Ferucarbotan (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 2003; 13: 1266-1276
10. Reimer P, Muller M, Marx C et al. T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration-preliminary clinical experience with dynamic T1-weighted MR imaging. Radiology 1998; 209: 831 -836
11. Muller M, Reimer P, Wiedermann D et al. T1-gewichtete dynamische MRT mit neuen superparamagnetischen Eisenoxidpartikeln (Resovist): Ergebnisse einer Studie am Phantom sowie an 25 Patienten. FortschrRöntgenstr 1998; 168: 228-236
12. Hagspiel KD, Neidl KF, Eichenberger AC et al. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995; 196: 471-478
13. Bellin MF, Zaim S, Auberton E et al. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 1994; 193: 657-663
14. Ward J, Chen F, Guthrie JA et al. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis. Radiology 2000; 214: 159-66
15. Vogl TJ, Hammerstingl R, Pegios W et al. Wertigkeit des leberspezifischen superparamagnetischen Kontrastmittels AMI-25 für die Detektion und Differentialdiagnose lebereigener Tumoren versus Metastasen. Fortschr Röntgenstr 1994; 160: 319-328
16. Vogl TJ, Schwarz W, Blume S et al. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MRI wit biphasic CTAP and intraoperative US. Eur Radiol 2003; 13: 262-272
17. Jung G, Cohnen M, Poll LW et al. Wertigkeit der CT und MRT in der Diagnostik von Lebermalignomen. Onkologe 2003; 9: 263-271
18. Bhartia B, Ward J, Guthrie JA et al. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin- section MR imaging with pathologic correlation of explanted tissue. Am J Roentgenol 2003; 180: 577-584
19. Jones EC, Chezmar JL, Nelson RC et al. The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. Am J Roentgenol 1992; 158: 535-539
20. Valls C, Andia E, Sanchez A et al. Hepatic Metastases from Colorectal Cancer: Preoperative Detection and Assessment of Resectability with Helical CT. Radiology 2001; 218: 55-60
21. Kumano S, Murakami T, Kim T et al. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors an non-solid benign lesions. Am J Roentgenol 2003; 181: 1335-1339
22. Montet X, Lazeyras F, Howarth N et al. Specifity of SPIO particles for characterization of liver hemangiomas using MRI. Abdom Imaging 2004; 29: 60-70
23. Habermann CR, Weiss F, Hillner M et al. Stellenwert der dreiphasischen Spiral-CT in der Detektion des hepatozellulären Karzinoms bei Leberzirrhose. Fortschr Röntgenstr 2002; 174: 96-100
24. Iannaccone R, Laghi A, Catalano C et al. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology 2005; 234: 460-467
25. Kim MJ, Kim JH, Chung JJ et al. Focal hepatic lesions: detection and characterization with combination Gadolinium- and superparamagnetic iron-oxide MRI. Radiology 2003; 228: 719-726
26. Vogl TJ, Hammerstingl R, Schwarz W et al. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996; 198: 881-887
27. Bluemke DA, Weber TW, Rubin D et al. Hepatic MRI with ferrumoxides: multicenter study of savety and effectiveness of direct injection protocol. Radiology 2003; 228: 457-464